Penserra Capital Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Penserra Capital Management’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,175	Closed	-$11K	–	1124
2022 Q2	$11K	Sell	4,175 -536	-11%	-$2K	﹤0.01%	1228
2022 Q1	$20K	Sell	4,711 -1,148	-20%	-$4.71K	﹤0.01%	1254
2021 Q4	$30K	Buy	5,859 +895	+18%	+$4.79K	﹤0.01%	1148
2021 Q3	$30K	Buy	4,964 +210	+4%	+$1.67K	﹤0.01%	1181
2021 Q2	$48K	Sell	4,754 -1,199	-20%	-$13K	﹤0.01%	1012
2021 Q1	$82K	Buy	+5,953	New	+$82.5K	﹤0.01%	718

Other funds holding NAUT

AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return